2024 Q2 Form 10-K Financial Statement
#000190359624000245 Filed on April 16, 2024
Income Statement
Concept | 2024 Q2 | 2023 Q4 | 2023 |
---|---|---|---|
Revenue | |||
YoY Change | |||
Cost Of Revenue | |||
YoY Change | |||
Gross Profit | |||
YoY Change | |||
Gross Profit Margin | |||
Selling, General & Admin | |||
YoY Change | |||
% of Gross Profit | |||
Research & Development | $436.4K | ||
YoY Change | 285.36% | ||
% of Gross Profit | |||
Depreciation & Amortization | |||
YoY Change | |||
% of Gross Profit | |||
Operating Expenses | $436.4K | ||
YoY Change | 285.36% | ||
Operating Profit | -$343.0K | $1.454M | |
YoY Change | 32.98% | 159.39% | |
Interest Expense | $14.16K | $15.71K | |
YoY Change | 444.69% | 11.7% | |
% of Operating Profit | 1.08% | ||
Other Income/Expense, Net | -$1.003M | ||
YoY Change | 147.79% | ||
Pretax Income | -$364.2K | -$2.457M | |
YoY Change | -37.58% | 154.53% | |
Income Tax | |||
% Of Pretax Income | |||
Net Earnings | -$364.2K | -$2.457M | |
YoY Change | -37.58% | 154.53% | |
Net Earnings / Revenue | |||
Basic Earnings Per Share | $0.00 | ||
Diluted Earnings Per Share | $0.00 | ||
COMMON SHARES | |||
Basic Shares Outstanding | 159.0M shares | 154.4M shares | |
Diluted Shares Outstanding | 159.0M shares |
Balance Sheet
Concept | 2024 Q2 | 2023 Q4 | 2023 |
---|---|---|---|
SHORT-TERM ASSETS | |||
Cash & Short-Term Investments | |||
YoY Change | |||
Cash & Equivalents | $201.9K | $108.3K | |
Short-Term Investments | |||
Other Short-Term Assets | |||
YoY Change | |||
Inventory | |||
Prepaid Expenses | $44.25K | $4.133K | |
Receivables | |||
Other Receivables | |||
Total Short-Term Assets | $246.2K | $112.5K | |
YoY Change | -78.21% | ||
LONG-TERM ASSETS | |||
Property, Plant & Equipment | |||
YoY Change | |||
Goodwill | |||
YoY Change | |||
Intangibles | |||
YoY Change | |||
Long-Term Investments | |||
YoY Change | |||
Other Assets | |||
YoY Change | |||
Total Long-Term Assets | $0.00 | $0.00 | |
YoY Change | |||
TOTAL ASSETS | |||
Total Short-Term Assets | $246.2K | $112.5K | |
Total Long-Term Assets | $0.00 | $0.00 | |
Total Assets | $246.2K | $112.5K | |
YoY Change | -78.21% | ||
SHORT-TERM LIABILITIES | |||
YoY Change | |||
Accounts Payable | |||
YoY Change | |||
Accrued Expenses | |||
YoY Change | |||
Deferred Revenue | |||
YoY Change | |||
Short-Term Debt | |||
YoY Change | |||
Long-Term Debt Due | |||
YoY Change | |||
Total Short-Term Liabilities | $2.258M | $1.574M | |
YoY Change | 17.26% | ||
LONG-TERM LIABILITIES | |||
Long-Term Debt | |||
YoY Change | |||
Other Long-Term Liabilities | |||
YoY Change | |||
Total Long-Term Liabilities | |||
YoY Change | |||
TOTAL LIABILITIES | |||
Total Short-Term Liabilities | $2.258M | $1.574M | |
Total Long-Term Liabilities | |||
Total Liabilities | $2.258M | $1.574M | |
YoY Change | 17.26% | ||
SHAREHOLDERS EQUITY | |||
Retained Earnings | -$6.218M | -$4.242M | |
YoY Change | 137.55% | ||
Common Stock | $159.0K | $155.5K | |
YoY Change | -50.68% | ||
Preferred Stock | |||
YoY Change | |||
Treasury Stock (at cost) | |||
YoY Change | |||
Treasury Stock Shares | |||
Shareholders Equity | -$2.012M | -$1.462M | |
YoY Change | |||
Total Liabilities & Shareholders Equity | $246.2K | $112.5K | |
YoY Change | -78.21% |
Cashflow Statement
Concept | 2024 Q2 | 2023 Q4 | 2023 |
---|---|---|---|
OPERATING ACTIVITIES | |||
Net Income | -$364.2K | -$2.457M | |
YoY Change | -37.58% | 154.53% | |
Depreciation, Depletion And Amortization | |||
YoY Change | |||
Cash From Operating Activities | -$647.9K | ||
YoY Change | 45.65% | ||
INVESTING ACTIVITIES | |||
Capital Expenditures | |||
YoY Change | |||
Acquisitions | |||
YoY Change | |||
Other Investing Activities | |||
YoY Change | |||
Cash From Investing Activities | |||
YoY Change | |||
FINANCING ACTIVITIES | |||
Cash Dividend Paid | |||
YoY Change | |||
Common Stock Issuance & Retirement, Net | |||
YoY Change | |||
Debt Paid & Issued, Net | |||
YoY Change | |||
Cash From Financing Activities | $240.0K | ||
YoY Change | -71.29% | ||
NET CHANGE | |||
Cash From Operating Activities | -$647.9K | ||
Cash From Investing Activities | |||
Cash From Financing Activities | $240.0K | ||
Net Change In Cash | -$407.9K | ||
YoY Change | -204.26% | ||
FREE CASH FLOW | |||
Cash From Operating Activities | -$647.9K | ||
Capital Expenditures | |||
Free Cash Flow | |||
YoY Change |
Facts In Submission
Frame | Concept Type | Concept / XBRL Key | Value | Unit |
---|---|---|---|---|
CY2023 | dei |
Entity Central Index Key
EntityCentralIndexKey
|
0001960262 | |
CY2022Q4 | us-gaap |
Prepaid Expense Current
PrepaidExpenseCurrent
|
usd | |
CY2023 | us-gaap |
Revenues
Revenues
|
usd | |
CY2022 | us-gaap |
Revenues
Revenues
|
usd | |
CY2023 | us-gaap |
Cost Of Revenue
CostOfRevenue
|
usd | |
CY2022 | us-gaap |
Cost Of Revenue
CostOfRevenue
|
usd | |
CY2023 | us-gaap |
Gross Profit
GrossProfit
|
usd | |
CY2022 | us-gaap |
Gross Profit
GrossProfit
|
usd | |
CY2023 | us-gaap |
Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
|
usd | |
CY2022 | ludg |
Inducement Expense One
InducementExpenseOne
|
usd | |
CY2022 | us-gaap |
Income Tax Expense Benefit
IncomeTaxExpenseBenefit
|
usd | |
CY2022 | ludg |
Cancellation Of Common Stock
CancellationOfCommonStock
|
usd | |
CY2023 | ludg |
Stock Issued For Services Related Party1
StockIssuedForServicesRelatedParty1
|
usd | |
CY2023 | ludg |
Stock Issued For Option To Acquire Common Stock
StockIssuedForOptionToAcquireCommonStock
|
usd | |
CY2022 | ludg |
Stock Issued For License Fee1
StockIssuedForLicenseFee1
|
usd | |
CY2023 | ludg |
Stock Issued During Period Value Purchase Of Asset
StockIssuedDuringPeriodValuePurchaseOfAsset
|
usd | |
CY2022 | ludg |
Inducement Expense
InducementExpense
|
usd | |
CY2023 | us-gaap |
Extinguishment Of Debt Gain Loss Net Of Tax
ExtinguishmentOfDebtGainLossNetOfTax
|
usd | |
CY2022 | us-gaap |
Increase Decrease In Prepaid Expenses Other
IncreaseDecreaseInPrepaidExpensesOther
|
usd | |
CY2023 | us-gaap |
Proceeds From Issuance Of Redeemable Preferred Stock
ProceedsFromIssuanceOfRedeemablePreferredStock
|
usd | |
CY2023 | us-gaap |
Proceeds From Notes Payable
ProceedsFromNotesPayable
|
usd | |
CY2022 | us-gaap |
Proceeds From Notes Payable
ProceedsFromNotesPayable
|
usd | |
CY2023 | us-gaap |
Interest Paid
InterestPaid
|
usd | |
CY2022 | us-gaap |
Interest Paid
InterestPaid
|
usd | |
CY2023 | us-gaap |
Income Taxes Paid Net
IncomeTaxesPaidNet
|
usd | |
CY2022 | us-gaap |
Income Taxes Paid Net
IncomeTaxesPaidNet
|
usd | |
CY2023 | ludg |
Conversion Of Accrued Interest Into Convertible Notes Payable
ConversionOfAccruedInterestIntoConvertibleNotesPayable
|
usd | |
CY2022 | ludg |
Conversion Of Notes Payable Into Common Stock
ConversionOfNotesPayableIntoCommonStock
|
usd | |
CY2023 | ludg |
Debt Discount Beneficial Conversion Feature One
DebtDiscountBeneficialConversionFeatureOne
|
usd | |
CY2022 | ludg |
Stock Repurchased And Returnable In Exchange For Note Payable Related Party
StockRepurchasedAndReturnableInExchangeForNotePayableRelatedParty
|
usd | |
CY2021Q4 | us-gaap |
Convertible Notes Payable
ConvertibleNotesPayable
|
usd | |
CY2023Q4 | us-gaap |
Debt Instrument Unamortized Discount
DebtInstrumentUnamortizedDiscount
|
usd | |
CY2023 | us-gaap |
Income Tax Expense Benefit Continuing Operations Adjustment Of Deferred Tax Asset Liability
IncomeTaxExpenseBenefitContinuingOperationsAdjustmentOfDeferredTaxAssetLiability
|
usd | |
CY2023 | us-gaap |
Income Tax Expense Benefit
IncomeTaxExpenseBenefit
|
usd | |
CY2022 | us-gaap |
Income Tax Expense Benefit
IncomeTaxExpenseBenefit
|
usd | |
CY2023Q4 | us-gaap |
Deferred Tax Assets Liabilities Net
DeferredTaxAssetsLiabilitiesNet
|
usd | |
CY2022Q4 | us-gaap |
Deferred Tax Assets Liabilities Net
DeferredTaxAssetsLiabilitiesNet
|
usd | |
CY2023 | dei |
Document Type
DocumentType
|
10-K | |
CY2023 | dei |
Document Annual Report
DocumentAnnualReport
|
true | |
CY2023 | dei |
Document Period End Date
DocumentPeriodEndDate
|
2023-12-31 | |
CY2023 | dei |
Current Fiscal Year End Date
CurrentFiscalYearEndDate
|
--12-31 | |
CY2023 | dei |
Entity Well Known Seasoned Issuer
EntityWellKnownSeasonedIssuer
|
No | |
CY2023 | dei |
Entity Well Known Seasoned Issuer
EntityWellKnownSeasonedIssuer
|
No | |
CY2023 | dei |
Entity Voluntary Filers
EntityVoluntaryFilers
|
No | |
CY2023 | dei |
Entity Current Reporting Status
EntityCurrentReportingStatus
|
Yes | |
CY2023 | dei |
Entity Interactive Data Current
EntityInteractiveDataCurrent
|
Yes | |
CY2023 | dei |
Entity Small Business
EntitySmallBusiness
|
true | |
CY2023 | dei |
Entity Filer Category
EntityFilerCategory
|
Non-accelerated Filer | |
CY2023 | dei |
Entity Emerging Growth Company
EntityEmergingGrowthCompany
|
true | |
CY2023 | dei |
Entity Ex Transition Period
EntityExTransitionPeriod
|
false | |
CY2023 | dei |
Document Fin Stmt Error Correction Flag
DocumentFinStmtErrorCorrectionFlag
|
false | |
CY2023Q2 | dei |
Entity Public Float
EntityPublicFloat
|
32575000 | usd |
CY2023 | dei |
Document Period End Date
DocumentPeriodEndDate
|
2023-12-31 | |
CY2023 | dei |
Auditor Firm
AuditorFirmId
|
5036 | |
CY2023 | dei |
Auditor Location
AuditorLocation
|
Margate, Florida | |
CY2023 | dei |
Auditor Name
AuditorName
|
Assurance Dimensions | |
CY2022Q4 | us-gaap |
Cash
Cash
|
516195 | usd |
CY2023Q4 | us-gaap |
Assets Current
AssetsCurrent
|
112468 | usd |
CY2022Q4 | us-gaap |
Assets Current
AssetsCurrent
|
516195 | usd |
CY2023Q4 | us-gaap |
Assets
Assets
|
112468 | usd |
CY2022Q4 | us-gaap |
Assets
Assets
|
516195 | usd |
CY2023Q4 | us-gaap |
Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
|
204024 | usd |
CY2022Q4 | us-gaap |
Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
|
6882 | usd |
CY2023Q4 | us-gaap |
Notes Payable Current
NotesPayableCurrent
|
1270009 | usd |
CY2022Q4 | us-gaap |
Notes Payable Current
NotesPayableCurrent
|
507136 | usd |
CY2023Q4 | us-gaap |
Convertible Notes Payable Current
ConvertibleNotesPayableCurrent
|
100000 | usd |
CY2022Q4 | us-gaap |
Convertible Notes Payable Current
ConvertibleNotesPayableCurrent
|
828344 | usd |
CY2023Q4 | us-gaap |
Liabilities Current
LiabilitiesCurrent
|
1574033 | usd |
CY2022Q4 | us-gaap |
Liabilities Current
LiabilitiesCurrent
|
1342362 | usd |
CY2023Q4 | us-gaap |
Liabilities
Liabilities
|
1574033 | usd |
CY2022Q4 | us-gaap |
Liabilities
Liabilities
|
1342362 | usd |
CY2023Q4 | us-gaap |
Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
|
7000000 | shares |
CY2022Q4 | us-gaap |
Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
|
7000000 | shares |
CY2023Q4 | us-gaap |
Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
|
0.001 | |
CY2023Q4 | us-gaap |
Preferred Stock Shares Issued
PreferredStockSharesIssued
|
7000000 | shares |
CY2023Q4 | us-gaap |
Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
|
7000000 | shares |
CY2022Q4 | us-gaap |
Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
|
7000000 | shares |
CY2022Q4 | us-gaap |
Preferred Stock Shares Issued
PreferredStockSharesIssued
|
7000000 | shares |
CY2023Q4 | us-gaap |
Preferred Stock Value
PreferredStockValue
|
7000 | usd |
CY2022Q4 | us-gaap |
Preferred Stock Value
PreferredStockValue
|
7000 | usd |
CY2023Q4 | us-gaap |
Common Stock Shares Authorized
CommonStockSharesAuthorized
|
1250000000 | shares |
CY2022Q4 | us-gaap |
Common Stock Shares Authorized
CommonStockSharesAuthorized
|
1250000000 | shares |
CY2023Q4 | us-gaap |
Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
|
0.001 | |
CY2022Q4 | us-gaap |
Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
|
0.001 | |
CY2023Q4 | us-gaap |
Common Stock Shares Issued
CommonStockSharesIssued
|
155464808 | shares |
CY2023Q4 | us-gaap |
Common Stock Shares Outstanding
CommonStockSharesOutstanding
|
155464808 | shares |
CY2022Q4 | us-gaap |
Common Stock Shares Issued
CommonStockSharesIssued
|
315188929 | shares |
CY2022Q4 | us-gaap |
Common Stock Shares Outstanding
CommonStockSharesOutstanding
|
315188929 | shares |
CY2023Q4 | us-gaap |
Common Stock Value
CommonStockValue
|
155463 | usd |
CY2023Q4 | us-gaap |
Additional Paid In Capital
AdditionalPaidInCapital
|
2618454 | usd |
CY2022Q4 | us-gaap |
Additional Paid In Capital
AdditionalPaidInCapital
|
637577 | usd |
CY2023Q4 | us-gaap |
Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
|
-4242482 | usd |
CY2022Q4 | us-gaap |
Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
|
-1785932 | usd |
CY2023Q4 | us-gaap |
Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
|
-1461565 | usd |
CY2022Q4 | us-gaap |
Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
|
-826167 | usd |
CY2023Q4 | us-gaap |
Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
|
112468 | usd |
CY2022Q4 | us-gaap |
Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
|
516195 | usd |
CY2023 | us-gaap |
Other General Expense
OtherGeneralExpense
|
1017470 | usd |
CY2022 | us-gaap |
Other General Expense
OtherGeneralExpense
|
447260 | usd |
CY2023 | ludg |
Research And Development In Expenses
ResearchAndDevelopmentInExpenses
|
436398 | usd |
CY2022 | ludg |
Research And Development In Expenses
ResearchAndDevelopmentInExpenses
|
113245 | usd |
CY2023 | us-gaap |
Operating Income Loss
OperatingIncomeLoss
|
1453868 | usd |
CY2022 | us-gaap |
Operating Income Loss
OperatingIncomeLoss
|
560505 | usd |
CY2023 | us-gaap |
Income Loss Attributable To Parent
IncomeLossAttributableToParent
|
-1453868 | usd |
CY2022 | us-gaap |
Income Loss Attributable To Parent
IncomeLossAttributableToParent
|
-560505 | usd |
CY2022 | us-gaap |
Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
|
44475 | usd |
CY2023 | ludg |
Inducement Expense One
InducementExpenseOne
|
-517454 | usd |
CY2022 | us-gaap |
Interest Expense
InterestExpense
|
14068 | usd |
CY2023 | ludg |
Amortization Of Debt Discount
AmortizationOfDebtDiscount
|
-469514 | usd |
CY2022 | ludg |
Amortization Of Debt Discount
AmortizationOfDebtDiscount
|
-435052 | usd |
CY2023 | us-gaap |
Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
|
-1002682 | usd |
CY2022 | us-gaap |
Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
|
-404645 | usd |
CY2023 | us-gaap |
Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
|
-2456550 | usd |
CY2022 | us-gaap |
Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
|
-965150 | usd |
CY2022 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-965150 | usd |
CY2023 | ludg |
Basic And Diluted Loss Per Common Share
BasicAndDilutedLossPerCommonShare
|
-0.01 | |
CY2022 | ludg |
Basic And Diluted Loss Per Common Share
BasicAndDilutedLossPerCommonShare
|
-0.00 | |
CY2023 | ludg |
Weighted Average Number Of Common Shares Outstanding Basic And Diluted
WeightedAverageNumberOfCommonSharesOutstandingBasicAndDiluted
|
286563789 | shares |
CY2022 | ludg |
Weighted Average Number Of Common Shares Outstanding Basic And Diluted
WeightedAverageNumberOfCommonSharesOutstandingBasicAndDiluted
|
313736463 | shares |
CY2022 | us-gaap |
Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
|
6000 | usd |
CY2022 | us-gaap |
Stock Issued During Period Value Acquisitions
StockIssuedDuringPeriodValueAcquisitions
|
1000 | usd |
CY2022 | us-gaap |
Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
|
91500 | usd |
CY2022 | ludg |
Stock Issued For Services Related Party
StockIssuedForServicesRelatedParty
|
5200 | usd |
CY2022 | ludg |
Stock Issued For Asset Purchase
StockIssuedForAssetPurchase
|
18000 | usd |
CY2022 | ludg |
Debt Discount Beneficial Conversion Feature
DebtDiscountBeneficialConversionFeature
|
75000 | usd |
CY2022 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-965150 | usd |
CY2022Q4 | us-gaap |
Stockholders Equity
StockholdersEquity
|
-826167 | usd |
CY2023 | ludg |
Stock Issued For License Fee
StockIssuedForLicenseFee
|
370000 | usd |
CY2023 | us-gaap |
Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
|
258713 | usd |
CY2023 | ludg |
Stock Issued For Conversion Of Debt Including Inducement Expense
StockIssuedForConversionOfDebtIncludingInducementExpense
|
950152 | usd |
CY2023 | ludg |
Stock Issued In Connection With Extension Of Notes And Convertible Notes Including Inducement Expense
StockIssuedInConnectionWithExtensionOfNotesAndConvertibleNotesIncludingInducementExpense
|
365160 | usd |
CY2023 | ludg |
Stock Repurchased Exchange For Note Payable Related Party Net And Stock Cancelled
StockRepurchasedExchangeForNotePayableRelatedPartyNetAndStockCancelled
|
-122873 | usd |
CY2023 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-2456550 | usd |
CY2023Q4 | us-gaap |
Stockholders Equity
StockholdersEquity
|
-1461565 | usd |
CY2023 | us-gaap |
Profit Loss
ProfitLoss
|
-2456550 | usd |
CY2022 | us-gaap |
Profit Loss
ProfitLoss
|
-965150 | usd |
CY2023 | ludg |
Stock Issued For Services
StockIssuedForServices
|
-258713 | usd |
CY2022 | ludg |
Stock Issued For Services
StockIssuedForServices
|
-91500 | usd |
CY2022 | ludg |
Stock Issued For Services Related Party1
StockIssuedForServicesRelatedParty1
|
5200 | usd |
CY2022 | ludg |
Stock Issued For Option To Acquire Common Stock
StockIssuedForOptionToAcquireCommonStock
|
-1000 | usd |
CY2023 | ludg |
Stock Issued For License Fee1
StockIssuedForLicenseFee1
|
370000 | usd |
CY2022 | ludg |
Stock Issued During Period Value Purchase Of Asset
StockIssuedDuringPeriodValuePurchaseOfAsset
|
18000 | usd |
CY2023 | ludg |
Amortization Of Debt Discount Premium One
AmortizationOfDebtDiscountPremiumOne
|
469514 | usd |
CY2022 | ludg |
Amortization Of Debt Discount Premium One
AmortizationOfDebtDiscountPremiumOne
|
435052 | usd |
CY2023 | ludg |
Inducement Expense
InducementExpense
|
517454 | usd |
CY2022 | us-gaap |
Extinguishment Of Debt Gain Loss Net Of Tax
ExtinguishmentOfDebtGainLossNetOfTax
|
44475 | usd |
CY2023 | us-gaap |
Increase Decrease In Prepaid Expenses Other
IncreaseDecreaseInPrepaidExpensesOther
|
4133 | usd |
CY2023 | us-gaap |
Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
|
197142 | usd |
CY2022 | us-gaap |
Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
|
14068 | usd |
CY2023 | us-gaap |
Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
|
-647860 | usd |
CY2022 | us-gaap |
Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
|
-444805 | usd |
CY2022 | us-gaap |
Proceeds From Issuance Of Redeemable Preferred Stock
ProceedsFromIssuanceOfRedeemablePreferredStock
|
6000 | usd |
CY2023 | us-gaap |
Proceeds From Issuance Of Convertible Preferred Stock
ProceedsFromIssuanceOfConvertiblePreferredStock
|
240000 | usd |
CY2022 | us-gaap |
Proceeds From Issuance Of Convertible Preferred Stock
ProceedsFromIssuanceOfConvertiblePreferredStock
|
830000 | usd |
CY2023 | us-gaap |
Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
|
240000 | usd |
CY2022 | us-gaap |
Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
|
836000 | usd |
CY2023 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
|
-407860 | usd |
CY2022 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
|
391195 | usd |
CY2022Q4 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
516195 | usd |
CY2021Q4 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
125000 | usd |
CY2023Q4 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
108335 | usd |
CY2022Q4 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
516195 | usd |
CY2023 | ludg |
Cancellation Of Common Stock1
CancellationOfCommonStock1
|
171163 | usd |
CY2022 | ludg |
Cancellation Of Common Stock1
CancellationOfCommonStock1
|
100 | usd |
CY2022 | ludg |
Conversion Of Accrued Interest Into Convertible Notes Payable
ConversionOfAccruedInterestIntoConvertibleNotesPayable
|
9473 | usd |
CY2023 | ludg |
Conversion Of Notes Payable Into Common Stock
ConversionOfNotesPayableIntoCommonStock
|
797858 | usd |
CY2023 | ludg |
Original Issuance Debt Discount
OriginalIssuanceDebtDiscount
|
65000 | usd |
CY2022 | ludg |
Original Issuance Debt Discount
OriginalIssuanceDebtDiscount
|
552857 | usd |
CY2022 | ludg |
Debt Discount Beneficial Conversion Feature One
DebtDiscountBeneficialConversionFeatureOne
|
75000 | usd |
CY2023 | ludg |
Reclassification From Convertible Notes To Notes Payable
ReclassificationFromConvertibleNotesToNotesPayable
|
640000 | usd |
CY2022 | ludg |
Reclassification From Convertible Notes To Notes Payable
ReclassificationFromConvertibleNotesToNotesPayable
|
507136 | usd |
CY2023 | ludg |
Stock Repurchased And Returnable In Exchange For Note Payable Related Party
StockRepurchasedAndReturnableInExchangeForNotePayableRelatedParty
|
122873 | usd |
CY2023 | ludg |
Net Loss
NetLoss
|
2456550 | usd |
CY2023 | ludg |
Net Cash Used In Operations
NetCashUsedInOperations
|
647860 | usd |
CY2023Q4 | us-gaap |
Retained Earnings Appropriated
RetainedEarningsAppropriated
|
4242482 | usd |
CY2023Q4 | ludg |
Working Capital Deficit
WorkingCapitalDeficit
|
1461565 | usd |
CY2023Q4 | us-gaap |
Cash
Cash
|
108335 | usd |
CY2023 | us-gaap |
Use Of Estimates
UseOfEstimates
|
<p id="xdx_843_eus-gaap--UseOfEstimates_z8kNdF11WsM9" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b><span id="xdx_86D_zxu7HXTxNL4">Use of Estimates</span></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Preparing financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and the disclosure of contingent assets and liabilities at the date of the financial statements and revenues and expenses during the reported period. Actual results could differ from those estimates, and those estimates may be material.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Changes in estimates are recorded in the period in which they become known. The Company bases its estimates on historical experience and other assumptions, which include both quantitative and qualitative assessments that it believes to be reasonable under the circumstances.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Significant estimates during the years ended December 31, 2023 and 2022 include valuation of stock-based compensation, uncertain tax positions, and the valuation allowance on deferred tax assets.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> | |
CY2023Q4 | us-gaap |
Cash Fdic Insured Amount
CashFDICInsuredAmount
|
0 | usd |
CY2022Q4 | us-gaap |
Cash Fdic Insured Amount
CashFDICInsuredAmount
|
256583 | usd |
CY2023 | us-gaap |
Research And Development Expense
ResearchAndDevelopmentExpense
|
436398 | usd |
CY2022 | us-gaap |
Research And Development Expense
ResearchAndDevelopmentExpense
|
113245 | usd |
CY2023 | us-gaap |
Advertising Expense
AdvertisingExpense
|
135576 | usd |
CY2022 | us-gaap |
Advertising Expense
AdvertisingExpense
|
79931 | usd |
CY2023 | us-gaap |
Payments For Repurchase Of Convertible Preferred Stock
PaymentsForRepurchaseOfConvertiblePreferredStock
|
700000000 | usd |
CY2022 | us-gaap |
Payments For Repurchase Of Convertible Preferred Stock
PaymentsForRepurchaseOfConvertiblePreferredStock
|
700000000 | usd |
CY2023 | us-gaap |
Prior Period Reclassification Adjustment Description
PriorPeriodReclassificationAdjustmentDescription
|
<p id="xdx_840_eus-gaap--PriorPeriodReclassificationAdjustmentDescription_z4fTxIEtPQad" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b><span id="xdx_866_z3bYObiHDoM7">New Accounting Standard Adopted</span></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b> </b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">In August 2020, FASB issued ASU 2020-06, Accounting for Convertible Instruments and Contracts in an Entity; Own Equity (“ASU 2020-06”), as part of its overall simplification initiative to reduce costs and complexity of applying accounting standards while maintaining or improving the usefulness of the information provided to users of financial statements. Among other changes, the new guidance removes from GAAP separation models for convertible debt that require the convertible debt to be separated into a debt and equity component, unless the conversion feature is required to be bifurcated and accounted for as a derivative or the debt is issued at a substantial premium. As a result, after adopting the guidance,</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">entities will no longer separately present such embedded conversion features in equity and will instead account for the convertible debt wholly as debt. The new guidance also requires use of the “if-converted” method when calculating the dilutive impact of convertible debt on earnings per share, which is consistent with the Company’s current accounting treatment under the current guidance. The guidance is effective for financial statements issued for fiscal years beginning after December 15, 2023, and interim periods within those fiscal years, with early adoption permitted, but only at the beginning of the fiscal year.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">This guidance will be adopted on January 1, 2024. The Company is evaluating the impact that the adoption of ASU 2020-06 might have on the Company’s consolidated financial statements.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">In March 2022, the Financial Accounting Standards Board (the “FASB”) issued ASU 2022-02, Financial Instruments – Credit Losses (Topic 326): Troubled Debt Restructurings and Vintage Disclosures (“ASU 2022-02”), which eliminates the accounting guidance on troubled debt restructurings (“TDRs”) for creditors in ASC 310, Receivables (Topic 310), and requires entities to provide disclosures about current period gross write-offs by year of origination. Also, ASU 2022-02 updates the requirements related to accounting for credit losses under ASC 326, Financial Instruments – Credit Losses (Topic 326), and adds enhanced disclosures for creditors with respect to loan refinancings and restructurings for borrowers experiencing financial difficulty. ASU 2022-02 was effective for the Company January 1, 2023. The adoption of ASU 2022-02 did not have a material impact on the Company’s consolidated financial statements.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">This guidance was adopted on January 1, 2023. The adoption of ASU 2022-02 did not have a material impact on the Company’s consolidated financial statements.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> | |
CY2021Q4 | us-gaap |
Notes Payable
NotesPayable
|
135955 | usd |
CY2022 | us-gaap |
Proceeds From Short Term Debt
ProceedsFromShortTermDebt
|
150000 | usd |
CY2022 | ludg |
Original Issue Debt Discount
OriginalIssueDebtDiscount
|
-75000 | usd |
CY2022 | ludg |
Amortization Of Debt Discount Premium1
AmortizationOfDebtDiscountPremium1
|
296181 | usd |
CY2022Q4 | us-gaap |
Notes Payable
NotesPayable
|
507136 | usd |
CY2023 | us-gaap |
Proceeds From Short Term Debt
ProceedsFromShortTermDebt
|
122873 | usd |
CY2022 | ludg |
Reclassifications Amount Net
ReclassificationsAmountNet
|
640000 | usd |
CY2023Q4 | us-gaap |
Notes Payable
NotesPayable
|
1270009 | usd |
CY2023Q4 | us-gaap |
Other Notes Payable Current
OtherNotesPayableCurrent
|
1270009 | usd |
CY2022Q4 | us-gaap |
Other Notes Payable Current
OtherNotesPayableCurrent
|
507136 | usd |
CY2022 | us-gaap |
Proceeds From Convertible Debt
ProceedsFromConvertibleDebt
|
1307857 | usd |
CY2022 | ludg |
Original Issue Debt Discount Convertible Notes Payable
OriginalIssueDebtDiscountConvertibleNotesPayable
|
-552857 | usd |
CY2022 | ludg |
Debt Discount Beneficial Conversion Feature Note1
DebtDiscountBeneficialConversionFeatureNote1
|
-75000 | usd |
CY2022 | ludg |
Convertible Notes Payable Note Discount
ConvertibleNotesPayableNoteDiscount
|
138871 | usd |
CY2022 | ludg |
Conversion Of Accrued Interest Into Convertible Notes Payable One
ConversionOfAccruedInterestIntoConvertibleNotesPayableOne
|
9473 | usd |
CY2022Q4 | us-gaap |
Convertible Notes Payable
ConvertibleNotesPayable
|
828344 | usd |
CY2023 | us-gaap |
Proceeds From Convertible Debt
ProceedsFromConvertibleDebt
|
305000 | usd |
CY2023 | ludg |
Debt Discount Beneficial Conversion Feature Note
DebtDiscountBeneficialConversionFeatureNote
|
-640000 | usd |
CY2023 | ludg |
Convertible Notes Payable Note Discount
ConvertibleNotesPayableNoteDiscount
|
-65000 | usd |
CY2023 | ludg |
Amortization Of Debt Discount1
AmortizationOfDebtDiscount1
|
469514 | usd |
CY2023 | ludg |
Conversion Of Debt Into Common Stock One
ConversionOfDebtIntoCommonStockOne
|
-797858 | usd |
CY2023Q4 | us-gaap |
Convertible Notes Payable
ConvertibleNotesPayable
|
100000 | usd |
CY2023Q4 | us-gaap |
Long Term Debt
LongTermDebt
|
100000 | usd |
CY2022Q4 | us-gaap |
Long Term Debt
LongTermDebt
|
1232857 | usd |
CY2022Q4 | us-gaap |
Debt Instrument Unamortized Discount
DebtInstrumentUnamortizedDiscount
|
404513 | usd |
CY2023Q4 | ludg |
Convertible Notes Payable Net
ConvertibleNotesPayableNet
|
100000 | usd |
CY2022Q4 | ludg |
Convertible Notes Payable Net
ConvertibleNotesPayableNet
|
828344 | usd |
CY2023Q4 | ludg |
Fair Value Of Common Stock On Conversion Date
FairValueOfCommonStockOnConversionDate
|
445714 | usd |
CY2023Q4 | ludg |
Fair Value Of Debt Subject To Inducement
FairValueOfDebtSubjectToInducement
|
342857 | usd |
CY2023Q4 | ludg |
Inducement Debt Expense
InducementDebtExpense
|
102857 | usd |
CY2023 | ludg |
Debtprior To Modification
DebtpriorToModification
|
151611 | usd |
CY2023 | ludg |
Debtafter Modification
DebtafterModification
|
107136 | usd |
CY2023 | ludg |
Gain On Debt Extinguishment
GainOnDebtExtinguishment
|
44475 | usd |
CY2023 | ludg |
Monthly Payment
MonthlyPayment
|
3750 | usd |
CY2023 | ludg |
Accrued Monthly
AccruedMonthly
|
5000 | usd |
CY2023 | ludg |
Monthly Payment Second
MonthlyPaymentSecond
|
5000 | usd |
CY2023 | ludg |
Second Accrued Monthly
SecondAccruedMonthly
|
3750 | usd |
CY2023 | us-gaap |
Deferred Federal Income Tax Expense Benefit
DeferredFederalIncomeTaxExpenseBenefit
|
-177000 | usd |
CY2022 | us-gaap |
Deferred Federal Income Tax Expense Benefit
DeferredFederalIncomeTaxExpenseBenefit
|
-194000 | usd |
CY2023 | us-gaap |
Deferred State And Local Income Tax Expense Benefit
DeferredStateAndLocalIncomeTaxExpenseBenefit
|
-37000 | usd |
CY2022 | us-gaap |
Deferred State And Local Income Tax Expense Benefit
DeferredStateAndLocalIncomeTaxExpenseBenefit
|
-43000 | usd |
CY2022 | us-gaap |
Income Tax Expense Benefit Continuing Operations Adjustment Of Deferred Tax Asset Liability
IncomeTaxExpenseBenefitContinuingOperationsAdjustmentOfDeferredTaxAssetLiability
|
-11000 | usd |
CY2023 | us-gaap |
Other Tax Expense Benefit
OtherTaxExpenseBenefit
|
-214000 | usd |
CY2022 | us-gaap |
Other Tax Expense Benefit
OtherTaxExpenseBenefit
|
-248000 | usd |
CY2023 | ludg |
Change In Valuation Allowance
ChangeInValuationAllowance
|
214000 | usd |
CY2022 | ludg |
Change In Valuation Allowance
ChangeInValuationAllowance
|
248000 | usd |
CY2023Q4 | ludg |
Debt Instrument Unamortized Discount1
DebtInstrumentUnamortizedDiscount1
|
119000 | usd |
CY2022Q4 | ludg |
Debt Instrument Unamortized Discount1
DebtInstrumentUnamortizedDiscount1
|
87000 | usd |
CY2023Q4 | ludg |
Share Based Payments
ShareBasedPayments
|
-290000 | usd |
CY2022Q4 | ludg |
Share Based Payments
ShareBasedPayments
|
-28000 | usd |
CY2023Q4 | us-gaap |
Deferred Tax Asset Interest Carryforward
DeferredTaxAssetInterestCarryforward
|
366000 | usd |
CY2022Q4 | us-gaap |
Deferred Tax Asset Interest Carryforward
DeferredTaxAssetInterestCarryforward
|
294000 | usd |
CY2023Q4 | us-gaap |
Deferred Tax Assets Gross
DeferredTaxAssetsGross
|
775000 | usd |
CY2022Q4 | us-gaap |
Deferred Tax Assets Gross
DeferredTaxAssetsGross
|
409000 | usd |
CY2023Q4 | us-gaap |
Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
|
775000 | usd |
CY2022Q4 | us-gaap |
Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
|
409000 | usd |